List of Glumetza drug patents

Glumetza is owned by Santarus Inc.

Glumetza contains Metformin Hydrochloride.

Glumetza has a total of 2 drug patents out of which 0 drug patents have expired.

Glumetza was authorised for market use on 03 June, 2005.

Glumetza is available in tablet, extended release;oral dosage forms.

The generics of Glumetza are possible to be released after 23 March, 2025.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7780987 SANTARUS INC Controlled release dosage forms
Mar, 2025

(2 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8323692 SANTARUS INC Controlled release dosage forms
Mar, 2023

(a month from now)

Drugs and Companies using METFORMIN HYDROCHLORIDE ingredient

Market Authorisation Date: 03 June, 2005

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of GLUMETZA before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in